Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
| Revenue (TTM) | $206.20M |
| Gross Profit (TTM) | $95.53M |
| EBITDA | $25.45M |
| Operating Margin | 14.00% |
| Return on Equity | 6.09% |
| Return on Assets | 0.56% |
| Revenue/Share (TTM) | $0.55 |
| Book Value | $2.92 |
| Price-to-Book | 1.28 |
| Price-to-Sales (TTM) | 6.45 |
| EV/Revenue | 3.099 |
| EV/EBITDA | 26.48 |
| Quarterly Earnings Growth (YoY) | -41.00% |
| Quarterly Revenue Growth (YoY) | 74.60% |
| Shares Outstanding | $368.41M |
| Float | $186.00M |
| % Insiders | 49.42% |
| % Institutions | 15.71% |
Volatility is currently expanding
Cronos Group NASDAQ: CRON reported record third-quarter revenue, gross profit and adjusted EBITDA as cannabis sales grew in Israel, Canada and Germany, while executives outlined plans to expand in Europe following the company's acquisition of Dutch cannabis producer CanAdelaar.
Cronos Group (CRON) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.07 per share a year ago.
Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count
Here is how Cronos Group (CRON) and Amgen (AMGN) have performed compared to their sector so far this year.
Cronos (CRON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027
TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, the #1 edible multipack in Canada1.
Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.
TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CRON and any ticker you trade — then tracks every position and per-strategy win rate.
